Derexin, known generically as Haloperidol Melitrexed, can be successfully discontinued. Fluperthiazide Melitracine is mainly used to treat mild to moderate depression and anxiety. Adverse reactions are rare and commonly include dizziness, tremor, dry mouth, constipation, and disturbed sleep. Concomitant use with monoamine oxidase inhibitors is prohibited. It is best not to use this product in pregnant and breastfeeding patients. Successful discontinuation of haloperidol meletrisine is achieved by gradually reducing the dose to discontinue it. Anxiety and depressive symptoms can be maintained for a period of time if they are under complete control after taking haloperidol meletrisine. After the symptoms do not return or there are no particularly unpleasant feelings, the dose can be reduced by 1/2 in 3 days and eventually discontinued successfully. For successful discontinuation of Haloperidol Melitrexed, a gradual approach to reducing the medication allows the patient to adapt and does not lead to a relapse of the disease. Flupirtidone Melitrexed should not be stopped abruptly, but must be slowly tapered as prescribed by the doctor until the medication is successfully discontinued. In the case of long-term treatment of mental illness, the patient must consult with the doctor how to stop the drug, and according to their own condition to choose the appropriate method of stopping the drug, more conducive to the cure of the disease.